News
12d
GlobalData on MSNFDA and EMA authorise AB Science’s Phase III trial of prostate cancer treatmentThe Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have authorised AB Science’s confirmatory ...
In eight tumors where patients failed immune checkpoint inhibitor (ICI) treatment, Plinabulin + radiation + PD-1 inhibitors demonstrated ...
TROPION-Lung01 is a global, randomised, multicentre, open-label Phase III trial evaluating the efficacy and safety of Datroway versus docetaxel in adult patients with locally advanced or metastatic ...
DATROWAY® (datopotamab deruxtecan-dlnk) has been approved in the US for the treatment of adult patients with locally advanced or metastatic EGFR-mutated non-small cell lung cancer (NSCLC) who ...
Ella lleva seis meses esperando por la reparación del equipo del hospital Domingo Luciani para que le hagan la radioterapia.
The newly launched Nothing Phone 3 boots with Nothing OS 3.5 out of the box. However, the next major OS update from the brand, the Nothing OS 4.0, based on Android 16, is now scheduled to be ...
During a live event, Jahan Aghalar, MD, discussed key NCCN-recommended oral therapies and landmark trials for metastatic prostate cancer.
Chrome OS Flex es un sistema operativo gratuito, ligero y seguro que revive computadoras antiguas con Windows o macOS. Ideal para tareas básicas, se instala fácilmente desde un USB y convierte ...
WILMINGTON, Del., June 24, 2025--DATROWAY® (datopotamab deruxtecan-dlnk) has been approved in the US for the treatment of adult patients with locally advanced or metastatic EGFR-mutated non-small ...
Catimel G, Verweij J, Mattijssen V, et al: Docetaxel (Taxotere): An active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck.
WILMINGTON, Del., June 24, 2025--DATROWAY® (datopotamab deruxtecan-dlnk) has been approved in the US for the treatment of adult patients with locally advanced or metastatic EGFR-mutated non-small cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results